Fractals: Life Science Conversations

Decoding the Real-World Language of Healthcare with Guest Jo Halliday

Episode Notes

Life sciences doesn’t have a data problem. It has a making-sense-of-the-data problem.

In this episode of Fractals: Life Science Conversations, Jo Halliday, CEO and Founder of Talking Medicines, joins host Colin Miller to explore how AI, natural language processing, and real-world signals can help life science organizations better understand what patients and healthcare professionals are actually saying—and turn those insights into better decisions.

From the episode:

• Why unstructured healthcare conversations can reveal insights traditional datasets miss
• How Talking Medicines evolved from collecting first-party patient data to analyzing signals across multiple sources
• What rapidly changing GLP-1 conversations tell us about increasingly informed and empowered patients
• How message resonance and behavioral trends can help pharma determine whether its communications are actually moving the needle
• Why the future of AI in life sciences will be less about the technology itself—and more about the questions it can help answer